Verquvo™ (vericiguat) approved in China to treat patients with chronic heart failure and reduced ejection fraction
Berlin, Germany, May 19, 2022 - Bayer announced today that China’s National Medical Products Administration (NMPA) has approved vericiguat under ...
Read moreDetails
